On Friday, November 29, shares of the small-cap biopharmaceutical company Applied Therapeutics plummeted 76% after the FDA declined to approve its drug to treat a rare genetic metabolic disease, jeopardizing its plans to launch its first commercial product. Applied Therapeutics, which is also pursuing drug approval in Europe, says it…
BI Group is set to announce the launch of sales for its latest overseas project: apartments on Dubai Islands, an artificial archipelago in the UAE. A month and a half ago, the Kazakhstani developer began offering projects in the U.S. «BI Group’s growth strategy spans 10 countries over 10 years,»…
Zacks Small-Cap Research (Zacks SCR) sees MediciNova, which develops treatments for amyotrophic lateral sclerosis (ALS) and pulmonary fibrosis, as significantly undervalued. In a recent Zacks SCR note, the stock’s fair value is estimated at $10 per share — five times its current price. MediciNova is set to receive compensation from pharmaceutical…
Small-cap stocks typically outperform the broader market from the Tuesday before Thanksgiving until the second trading day of the new year, points out Jeffrey Hirsch of Stock Trader’s Almanac. Historically, they have delivered stronger returns than their large-cap peers during this period, even with the so-called Santa Claus rally. Details…
Shares of U.S. drone manufacturer Unusual Machines, with a market capitalization of $75 million, more than doubled on Wednesday, November 27. The catalyst was the announcement that Donald Trump Jr., the son of the U.S. president-elect, had joined the company’s advisory board. Trump Jr. expressed his support for Unusual Machines’…
The Motley Fool has highlighted two small-cap investments of the world’s second-most valuable company, the chipmaker Nvidia. According to Nvidia’s financials, it holds shares of voice assistant developer SoundHound AI and Applied Digital, a builder of data centers. The Motley Fool encourages investors to follow Nvidia’s lead. SoundHound AI With…
Shares of Poseida Therapeutics, which develops cell and gene therapies for cancers and genetic diseases, skyrocketed nearly 230% on Tuesday, November 26. The surge came after the announcement of its acquisition by pharmaceutical giant Roche, with the deal valuing Poseida at $1.5 billion — triple its highest market value in…
Exchange rate volatility and high interest rates on tenge deposits make it challenging to objectively assess the trends in financial flows between banks and retail clients. To tackle these challenges, Kursiv.media sought to eliminate the impact of these two distorting factors to provide a clearer analysis. Kursiv.media surveyed Kazakhstan’s 10…
On Monday, November 25, quotes on the small-cap biotech company Cassava Sciences plunged almost 84% after the company reported that its Alzheimer’s treatment had failed in a clinical trial. Details On Monday, Cassava Sciences stock lost almost 84% on the Nasdaq to $4.30 per share. This marked the biggest percentage…
Thomas Yeung, an analyst at InvestorPlace Markets, has named three retreating small-cap stocks that he believes are poised for a turnaround in 2025. Two of the companies could benefit from the new administration of President-elect Donald Trump, while the third stands to gain from the trend of automation. Stratasys Stratasys,…
“There’s no doubt: the higher the levels of crime and violence, the greater the demand for our services,” says Eyal Sheratzky, co-CEO of Ituran, in an exclusive interview with Kursiv.Investments. This Israeli company, with a market capitalization of almost $580 million on the Nasdaq, provides satellite vehicle-tracking services. It helps…
Shares of small-cap biopharmaceutical company Citius Pharmaceuticals plummeted nearly 19% on Friday, November 22, hitting an all-time low after the company announced a reverse stock split to regain compliance with listing requirements. Details Citius Pharma’s stock dropped 18.8% on the Nasdaq on Friday to close at $0.13 per share —…
Lauren Romeo, a portfolio manager of three Royce funds, has highlighted a trio of innovative smaller companies whose stocks are high-confidence holdings. She points out that technological advances often stem not just from giants like Nvidia and Amazon but also from small-cap companies. MKS Instruments The first company is MKS…
Shares of Hong Kong-based ready-to-cook and ready-to-eat Asian food producer DayDayCook (DDC) rose nearly 10% on Thursday, November 21, following an announcement that the New York Stock Exchange had granted the company an extension to file its 2023 annual financial report. The new deadline is February 4, 2025. DDC has…
Shares of Sidus Space, a space services company, advanced nearly 6% on Thursday, November 21, before extending the gains in after-hours trading. This came after the company announced a partnership with the German start-up Reflex Aerospace to produce integrated satellite platforms together. Details On Thursday, Sidus Space stock gained almost…
Shares of video display and scoreboard manufacturer Daktronics fell over 5% on Wednesday, November 20. This came after it was announced that the company’s board of directors had amended its shareholder rights agreement to prevent an activist investor — a nominee proposed by Alta Fox Capital Management’s affiliates — from…
Innodata, a small-cap IT solutions provider that uses its large language models (LLMs) to train other companies’ AI, is like “Palantir in its early days,” according to Zacks. Today, Palantir is a leader in the AI sector with a market capitalization of more than $141.5 billion. Zacks strongly recommends buying…
Two air taxi stocks — Joby Aviation and Archer Aviation — have jumped after the investment bank Needham initiated coverage of them with “buy” ratings, as reported by Barron’s. Details On Tuesday, November 19, Needham launched coverage of Joby Aviation and Archer Aviation, rating them “buys.” This led to a…
Zacks Small-Cap Research (Zacks SCR) has raised its target price for BioStem Technologies, a developer of perinatal tissue-based therapies, believing the stock should trade at double its current market price. This comes after the company’s third-quarter financial results, which beat Wall Street expectations. Details Zacks SCR values BioStem Technologies stock…
In a recent report, Zacks Small-Cap Research (Zacks SCR) has made the case for its $30 per share target price for Achieve Life Sciences, which is seven times the last closing price. Achieve is a micro-cap company developing the world’s first treatment for vaping addiction. Details Zacks SCR values Achieve…
Shares of Liberty Energy, an oilfield services company, advanced about 5% on Monday, November 18, following the announcement by President-elect Donald Trump that he would nominate Liberty’s founder and CEO, Christopher Wright, as the next U.S. secretary of energy, as MarketWatch reports. Details On the news about Trump’s nomination of…
On Monday, November 18, shares of the crypto exchange Bakkt, majority-owned by major exchange operator Intercontinental Exchange, soared 162%. This came after a story by the FT that Trump Media & Technology Group (TMTG), which owns the Truth Social social media site of president-elect Donald Trump, is in “advanced talks”…
Spirit Airlines, a pioneer budget airline, has filed for bankruptcy after multiple failed merger attempts with competitors. The company claims to have reached an agreement with most creditors and expects to emerge from bankruptcy next year. Trading in Spirit Airlines shares, which have fallen more than 90% this year, has…
Shares of Citius Pharmaceuticals, a small company developing critical care products, plunged nearly 40% to an all-time low on Friday, November 15. The trigger was an announced direct offering at $0.25 per share. Details Citius Pharmaceuticals stock dropped almost 40% on the Nasdaq to a record-low of $0.20 per share…
